所属学会 日本外科学会 日本呼吸器外科学会 日本胸部外科学会 日本癌学会 日本臨床外科学会 日本肺癌学会 日本内視鏡外科学会 日本気管支内視鏡学会 日本気管食道学会 日本臨床腫瘍学会 日本胸腺研究会 American Society of Clinical Oncology (ASCO) International Association for the Study of Lung Cancer (IASLC)
学歴
出身大学院 2000 , 群馬大学
出身学校・専攻等（大学院を除く） 1993 , 群馬大学医学部
取得学位 医学博士 , 群馬大学
免許・資格等 199306 , 医師国家試験合格
受賞学術賞
2019 , General Thoracic and Cardiovascular Surgery (GTCS) Best reviewer award 2019 2018 , 群馬大学医師会賞 2017 , General Thoracic and Cardiovascular Surgery (GTCS) 優秀論文賞 2005 , 北関東医学会奨励賞
Development of a novel CAR-T cell therapy targeting ALK for small cell lung cancer CANCER SCIENCE,113:1485-1485 2022(Feb.) Author:Takeda, Tetsu; Hirabayashi, Koichi; Tanaka, Miyuki; Yagyu, Shigeki; Shimizu, Kimihiro; Nakazawa, Yozo;
A risk model for prolonged air leak after lobectomy using the National Clinical Database in Japan SURGERY TODAY,52(1):69-74 2022(Jan.) Author:Shintani, Yasushi; Yamamoto, Hiroyuki; Sato, Yukio; Shimizu, Kimihiro; Endo, Shunsuke; Okada, Morihito; Suzuki, Kenji; Fukuchi, Eriko; Miyata, Hiroaki; Chida, Masayuki; Keywords:Lung cancer; Lobectomy; Prolonged air leak; Risk model;
Right upper lobe segmentectomy guided by simplified anatomic models JTCVS Techniques,4:288-297 2020(Dec.) Author:Seshiru Nakazawa, Kimihiro Shimizu, Natsuko Kawatani, Kai Obayashi, Yoichi Ohtaki, Toshiteru Nagashima, Takashi Eguchi, Toshiki Yajima, and Ken Shirabe
Cancer exosomal microRNAs from gefitinib-resistant lung cancer cells cause therapeutic resistance in gefitinib-sensitive cells. Sugery Today,50(9):1099-1106 2020(Sep.) Author:Azuma Y,yokobori T,Mogi A, Yajima T, Kosaka T,Iijima M, Shimizu K, Shirabe K, Kuwano H
Interstitial lung disease secondary to after interstitial injury induced by crizotinib. Jornal of Cancer Research and Therapeutics,16(4):919-921 2020(Jul.) Author:Kaira K, Nasuse I, Shimizu K, Asao T
Diagnostic value of 18F-FDG-PET to predict the tumour immune status defined by tumoural PD-L1 and CD8+tumourinfiltrating lymphocytes in oral squamous cell carcinoma British Journal of Cancer,122(11):1686-1694 2020(May) Author:Togo M,Yokobori T,Shimizu K,Handa T,Kaira K,tsukagoshi M,higuchi T,Yokoo S,Shirabe K,Oyama T
Significance of RAS mutations in pulmonary metastases of patients with colorectal cancer. International journal of clinical oncology,25(4):641-650 2020(Apr.) Author:Igarashi T, Shimizu K, Usui K, Yokobori T, Ohtaki Y, Nakazawa S, Obayashi K, Yajima T, Nobusawa S, Ohkawa T,Katoh R, Motegi Y, Ogawa H, Harimoto N, Ichihara T, Mitani Y, Yokoo H, Mogi A, Shirabe K
Quantitative analysis of metabolic parameters at 18F‑fluorodeoxyglucose positron emission tomography in predicting malignant potential of anterior mediastinal tumors Oncology Letters,19(3):1865-1871 2020(Mar.) Author:Yajima T,Mogi A,Shimizu K,Kosaka T,Ohtaki Y,Obayashi K,Nakazawa S,Nakajima T,Tsushima Y,Shirabe K
High Stromal TGFBI in Lung Cancer and Intratumoral CD8-Positive T Cells were Associated with Poor Prognosis and Therapeutic Resistance to Immune Checkpoint Inhibitors. Annals of surgical oncology ,27(3):933-942 2020(Mar.) Author:Nakazawa N, Yokobori T, Kaira K, Turtoi A, Baatar S, Gombodorj N, Handa T, Tsukagoshi M, Ubukata Y, Kimura AKogure N, Ogata K, Maeno T, Sohda M, Yajima T, Shimizu K, Mogi A,Kuwano H, Saeki H, Shirabe K
Tuberculosis infection and lung adenocarcinoma: Mendelian randomization and pathway analysis of genome-wide association study data from never-smoking Asian women. Genomics ,112(2):1223-1232 2020(Mar.) Author:Wong JYY, Zhang H, Hsiung CA, et al.
Skeletal muscle predicts the outcome pf nivolmab treatment for non-small cell lung cancer. Medicine,99(7):e19059 2020(Feb.) Author:Tsukagoshi M, Yokobori T, Yajima T, Maeno T ,Shimizu K, Mogi A , Araki K, Harimoto N, Shirabe K, Kaira K
Prognostic Significance of Tumor Immunity in Surgically Resected Pulmonary Pleomorphic Carcinoma. Anticancer research ,40(1):261-269 2020(Jan.) Author:Kaira K, Shimizu K*, Endoh H, Imaizumi K, Kamiyoshihara M, Sugano M, Kawashima O, Tanaka S, Fujita A, Imai H, Kogure Y, Oyama T, Asao T, Shirabe K
Clinicopathological features of small-sized peripheral squamous cell lung cancer. Molecular and clinical oncology ,12(1):69-74 2020(Jan.) Author:Kosaka T, Shimizu K, Nakazawa S, Iijima M, Ohtaki Y, Azuma Y, Obayashi K, Nagashima T, Yajima T, Mogi A, Kuwano H, Shirabe K
Relationship Between Tumor Immune Markers and Fluorine-18-α-Methyltyrosine ([18F]FAMT) Uptake Patients with Lung Cancer. Molecular imaging and biology 2019(Dec.) Author:Shimizu K, Kaira K, Higuchi T, Hisada T, Yokobori T, Oyama T, Asao T,Tsushima Y, Shirabe K
Clinical Significance of Various Drug-Sensitivity Markers in Patients with Surgically Resected Pulmonary Pleomorphic Carcinoma. Cancers,11(11):1636 2019(Nov.) Author:Imai H, Shimizu K, Kawashima O, Endoh H, Imaizumi K, Goto Y, Kamiyoshihara M, Sugano M, Yamamoto R, Tanaka S, Fujita A, Kogure Y, Seki Y, Mogi A, Oyama T, Minato K, Asao T, Kaira K
Long-term complete response in a patient with postoperative recurrent ALK-rearranged lung adenocarcinoma treated with crizotinib: A case report. Molecular and clinical oncology ,11(3):309-312 2019(Sep.) Author:Kosaka T, Yajima T, Yamaki E, Nakazawa S,Tomizawa K, Onozato R, Yamazaki A, Hirato J, Yatabe Y, Shimizu K, Mogi A, Shirabe K
Pulmonary Artery Compression Facilitates Intersegmental Border Visualization. The Annals of thoracic surgery,108(2):e141-e143 2019(Aug.) Author:Yajima T, Shimizu K, Mogi A, Ibe T, Ohtaki Y, Obayashi K, Nakazawa S, Kawatani N, Shirabe K
Fluorodeoxyglucose uptake is associated with low tumor-infiltrating lymphocyte levels in patients with small cell lung cancer. Lung cancer (Amsterdam, Netherlands),134:180-186 2019(Aug.) Author:Kasahara N, Kaira K, Yamaguchi K, MasubuchiH, Tsurumaki H, Hara K,Koga Y, Sakurai R, Higuchi T, Handa T, Oyama T, Yokobori T, Shimizu K, Asao T, Hisada T
Stathmin-1 is a useful diagnostic marker for high-grade lung neuroendocrine tumors. Ann Thorac Surg,108(1):235-243 2019(Jul.) Author:Shimizu K, Goto Y, Kawabata-Iwakawa R, Ohtaki Y, Nakazawa S, Yokobori T, Obayashi K, Kawatani N, Yajima T, Kaira K,Mogi A, Hirato J, Nishiyama M, Shirabe K
Is salvage surgery for patients with lung cancer after carbon ion radiotherapy easy or difficult? Interactive cardiovascular and thoracic surgery,28(6):953-956 2019(Jun.) Author:Ohtaki Y, Shimizu K, Saitoh JI,,Kamiyoshihara M, Mogi A, Nakazawa S, Ohno T, Shirabe K
Genetic and Immunohistochemical Studies Investigating the Histogenesis of Neuroendocrine andCarcinomatous Components of Combined Neuroendocrine Carcinoma. Annals of surgical oncology,26(6):1744-1750 2019(Jun.) Author:Iijima M, Yokobori T, Mogi A, Shimizu K, Yajima T, Kosaka T, Ohtaki Y, Obayashi K, Nakazawa S, Gombodorj N,Tsukagoshi M, Shirabe K, Kuwano H
Outcomes and prognostic factors after pulmonary metastasectomy in patients with colorectal cancer with previously resected hepatic metastases. The Journal of thoracic andcardiovascular surgery,157(5):2049-2057 2019(May) Author:Shimizu K, Ohtaki Y, Okumura T, Boku N, Horio H, Takenoyama M,Yamashita M, Hyodo I, Mori K, Kondo H
Minimally invasive open-window thoracostomy using wound edge protectors. ,107(5):e371-e373 2019(May) Author:Shimizu K, Ohtaki Y, Nakazawa S, Obayashi K, Nagashima T, Yajima T, Mogi A, Shirabe K
Will minimally invasive sleeve resection become the future trend for treatment of advanced lung cancer? J Thorac Disease,11(4):1085-1087 2019(Apr.) Author:Kosaka T, Shimizu K, Nakazawa S, Obayashi K, Ohtaki Y, Kawatani N, Ibe T, Yajima T, Mogi A, Shirabe K
Thoracoscopic right middle lobe segmentectomy. General thoracic and cardiovascular surgery,67(3):344-347 2019(Mar.) Author:Yajima T, Shimizu K, Mogi A, Kosaka T, Nakazawa S, Shirabe K.
Medial-basal segment (S7)-sparing right basal segmentectomy. General thoracic and cardiovascular surgery,68(3):306-309 2019(Mar.) Author:Yajima T, Shimizu K, Mogi A, Kosaka T,Nakazawa S, Shirabe K
Expression of amino acid transporter (LAT1 and 4F2hc) in pulmonary pleomorphic carcinoma. Human pathology,84:142-149 2019(Feb.) Author:Kaira K, Kawashima O, Endoh H, Imaizumi K, Goto Y, Kamiyoshihara M, Sugano M, Yamamoto R, Osaki T, Tanaka S, Fujita A, Imai H, Kogure Y, Seki Y, Shimizu K, Mogi A, Shitara Y, Oyama T, Kanai Y, Asao T.
Carbonic anhydrase 9 expression is associated with poor prognosis, tumor proliferation, and radiosensitivity of thymic carcinomas. Oncotarget.,10(13):1306-1319 2019(Feb.) Author:Ohtaki Y, Shimizu K, Kawabata-Iwakawa R, Gombodorj N, Altan B, Rokudai S, Yamane A, Kaira K, Yokobori T, Nagashima T, Obayashi K, Nakazawa S, Iijima M, Kosaka T, Yajima T, Mogi A, Kuwano H, Shirabe K, Nishiyama M.
Prognostic Impact of β2 Adrenergic Receptor Expression in Surgically Resected Pulmonary Pleomorphic Carcinoma. Anticancer Res.,39(1):395-403 2019(Jan.) Author:Kaira K, Kamiyoshihara M, Kawashima O, Endoh H, Imaizumi K, Sugano M, Tanaka S, Fujita A, Kogure Y, Shimizu A, Oyama T, Asao T, Shimizu K, Mogi A.
Management of intraoperative bleeding during video-assisted thoracoscopic surgery. Journal of Viualizeds Surgery,4:245 2018(Dec.) Author:Nakazawa S, Shimizu K, Kawatani N, Obayashi K, Kosaka T, Ibe T, Yajima T, Mogi T, Shirabe K
Prognostic value of metabolic tumor volume of pretreatment 18F-FAMT PET/CT in non-small cell lung Cancer. BMC Med Imaging.,18(1):46 2018(Nov.) Author:Kumasaka S, Nakajima T, Arisaka Y, Tokue A, Achmad A, Fukushima Y, Shimizu K, Kaira K, Higuchi T, Tsushima Y.
Overall survival results of the feasibility study of adjuvant chemotherapy with docetaxel plus cisplatin followed by long-term single-agent administration of S-1 in patients with completely resected non-small cell lung cancer: Thoracic Oncology Research Group (TORG) 0809 American journal of clinical oncology,41(11):1113-1117 2018(Nov.) Author:Niho S, Ikeda N, Michimae H, Suzuki K, Sakai H, Kaburagi T, Yoshiya K, Minato K, Kato T, Okamoto H, Seto T, Hosomi Y, Shimizu K, Saito H, Tsuchida M, Kunitoh H, Tsuboi M, Takeuchi M, Watanabe K
A leopard can't change its spots: can a T790M mutation-positive cancer change its spots after epidermal growth factor receptor-tyrosine kinase inhibitor therapy? Journal of thoracic disease,10(Suppl 33):S4113-S4116 2018(Nov.) Author:Obayashi K, Shimizu K, Nakazawa S, Ohtaki Y, Kawatani N, Takashi I, Yajima T, Mogi A, Shirabe K.
Prognostic significance of PD-L1 expression and tumor infiltrating lymphocytes in large cell neuroendocrine carcinoma of lung. American journal of translational research,10(10):3243-3253 2018(Oct.) Author:Ohtaki Y, Kaira K, Atsumi J, Nagashima T, Kawashima O, Ibe T, Kamiyoshihara M, Onozato R, Fujita A, Yazawa T, Sugano M, Iijima M, Nakazawa S, Obayashi K, Kosaka T, Yajima T, Kuwano H, Shirabe K, Mogi A, Shimizu K.
Management of intraoperative bleeding during thoracoscopic pulmonary resection in Japan. Journal of Viualizeds Surgery,4:225-229 2018(Oct.) Author:Igai H, Kamiyoshihara M, Yoshikawa R, Ohsawa F, Tomohiro Y, Shimizu K
The impact of histology and ground-glass opacity component on volume doubling time in primary lung cancer. Journal of thoracic disease,10(9):5428-5434 2018(Sep.) Author:Obayashi K, Shimizu K, Nakazawa S, Nagashima T, Yajima T, Kosaka T, Atsumi J, Kawatani N, Yazawa T, Kaira K, Mogi A, Kuwano H.
2-Deoxy-2-[fluorine-18] fluoro-d-glucose uptake on positron emission tomography is associated with programmed death ligand-1 expression in patients with pulmonary adenocarcinoma. European journal of cancer (Oxford, England : 1990),101:181-190 2018(Sep.) Author:Kaira K, Shimizu K, Kitahara S, Yajima T, Atsumi J, Kosaka T, Ohtaki Y, Higuchi T, Oyama T, Asao T, Mogi A.
Correlation of tumor-related immunity with 18F-FDG-PET in pulmonary squamous-cell carcinoma. Lung Cancer.,119:71-77 2018(May) Author:Kasahara N, Kaira K, Bao P, Higuchi T, Arisaka Y, Erkhem-Ochir B, Sunaga N, Ohtaki Y, Yajima T, Kosaka T, Oyama T, Yokobori T, Asao T, Nishiyama M, Tsushima Y, Kuwano H, Shimizu K, Mogi A.
Ectopic thymoma in the paratracheal region of the middle mediastinum: a rare case report and literature review. BMC Res Notes. ,11(1):256 2018(Apr.) Author:Yajima T, Mogi A, Shimizu K, Kosaka T, Nagashima T, Ohtaki Y, Obayashi K, Nakazawa S, Iijima M, Yoshida Y, Hirato J, Kuwano H.
Clinical and Radiological Discrimination of Solitary Pulmonary Lesions in Colorectal Cancer Patients. World journal of surgery,42(4):1161-1170 2018(Apr.) Author:Ohtaki Y, Shimizu K, Nagashima T, Nakazawa S, Obayashi K, Azuma Y, Iijima M, Kosaka T, Yajima T, Ogawa H, Tsutsumi S, Arai M, Mogi A, Kuwano H.
Segmentectomy of the left superior segment (S6) 4 years after segmentectomy of the left dorsobasal segment (S10). The Journal of thoracic and cardiovascular surgery,155(3):1302-1304 2018(Mar.) Author:Shimizu K, Nakazawa S, Mogi A, Kuwano H.
High expression of carcinoembryonic antigen and telomerase reverse transcriptase in circulating tumor cells is associated with poor clinical response to the immune checkpoint inhibitor nivolumab Oncology letters,15(3):3061-3067 2018(Mar.) Author:Bao H, Bai T, Takata K, Yokobori T, Ohnaga T, Hisada T, Maeno T, Bao P, Yoshida T, Kumakura Y, Honjo H, Sakai M, Sohda M, Fukuchi M, Altan B, Handa T, Ide M, Miyazaki T, Ogata K, Oyama T, Shimizu K, Mogi A, Asao T, Shirabe K, Kuwano H, Kaira K
VATS segmentectomy: past, present, and future. General thoracic and cardiovascular surgery,66(2):81-90 2018(Feb.) Author:Nakazawa S, Shimizu K, Mogi A, Kuwano H
Low diffusing capacity, emphysema, or pulmonary fibrosis: who is truly pulling the lung cancer strings? Journal of thoracic disease,10(2):600-602 2018(Feb.) Author:Nakazawa S, Shimizu K, Mogi A, Kuwano H
Metabolic activity by 18F-FDG-PET/CT is predictive of early response after nivolumab in previously treated NSCLC. European journal of nuclear medicine and molecular imaging,45(1):56-66 2018(Jan.) Author:Kaira K, Higuchi T, Naruse I, Arisaka Y, Tokue A, Altan B, Suda S, Mogi A, Shimizu K, Sunaga N, Hisada T, Kitano S, Obinata H, Yokobori T, Mori K, Nishiyama M, Tsushima Y, Asao T
High STMN1 Expression is Associated with Cancer Progression and Chemo-Resistance in Lung Squamous Cell Carcinoma. Annals of surgical oncology,24(13):4017-4024 2017(Dec.) Author:Bao P, Yokobori T, Altan B, Iijima M, Azuma Y, Onozato R, Yajima T, Watanabe A, Mogi A, Shimizu K, Nagashima T, Ohtaki Y, Obayashi K, Nakazawa S, Bai T, Kawabata-Iwakawa R, Asao T, Kaira K, Nishiyama M, Kuwano H
Thoracoscopic Subsuperior Segment Segmentectomy. The Annals of thoracic surgery,104(5):e407-e410 2017(Nov.) Author:Shimizu K, Mogi A, Yajima T, Nagashima T, Ohtaki Y, Obayashi K, Nakazawa S, Kosaka T, Kuwano H
Thoracoscopic right upper lobectomy after an initial anatomic pulmonary resection of the lower lobe. Multimedia manual of cardiothoracic surgery : MMCTS,2017 2017(Nov.) Author:Igai H, Kamiyoshihara M, Kawatani N, Shimizu K
Thoracoscopic Medial-Basal Segment Segmentectomy. The Annals of thoracic surgery,104(5):e403-e406 2017(Nov.) Author:Shimizu K, Nagashima T, Yajima T, Ohtaki Y, Obayashi K, Nakazawa S, Kosaka T, Mogi A, Kuwano H
Prognostic impact of stathmin 1 expression in patients with lung adenocarcinoma. The Journal of thoracic and cardiovascular surgery,154(4):1406-1417000 2017(Oct.) Author:Shimizu K, Ohtaki Y, Altan B, Yokobori T, Nagashima T, Arai M, Mogi A, Kuwano H
3D-CT anatomy for VATS segmentectomy. Journal of visualized surgery,3:88 2017(Jul.) Author:Shimizu K, Nakazawa S, Nagashima T, Kuwano H, Mogi A
STXBP4 Drives Tumor Growth and Is Associated with Poor Prognosis through PDGF Receptor Signaling in Lung Squamous Cell Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research,23(13):3442-3452 2017(Jul.) Author:Otaka Y, Rokudai S, Kaira K, Fujieda M, Horikoshi I, Iwakawa-Kawabata R, Yoshiyama S, Yokobori T, Ohtaki Y, Shimizu K, Oyama T, Tamura J, Prives C, Nishiyama M
Analysis of variation in bronchovascular pattern of the right middle and lower lobes of the lung using three-dimensional CT angiography and bronchography. General thoracic and cardiovascular surgery,65(6):343-349 2017(Jun.) Author:Nagashima T, Shimizu K, Ohtaki Y, Obayashi K, Nakazawa S, Mogi A, Kuwano H
Three-Dimensional Computed Tomography Helps Identify Muscles for Use in an Empyema Cavity. The Annals of thoracic surgery,103(5):e457 2017(May) Author:Kamiyoshihara M, Ibe T, Kawatani N, Ohsawa F, Yoshikawa R, Shimizu K
Pulmonary artery reconstruction with a tailor-made bovine pericardial conduit following sleeve resection of a long segmental pulmonary artery for the treatment of lung cancer: technical details of the dog-ear method for adjusting diameter during vascular General thoracic and cardiovascular surgery,65(5):304-307 2017(May) Author:Shimizu K, Nagashima T, Ohtaki Y, Takahashi T, Mogi A, Kuwano H
Paraspinous muscle flap for the treatment of an empyema cavity: three case reports. General thoracic and cardiovascular surgery,65(5):297-301 2017(May) Author:Kamiyoshihara M, Ibe T, Igai H, Kawatani N, Ohsawa F, Yoshikawa R, Shimizu K
Histology is a Prognostic Indicator After Pulmonary Metastasectomy from Renal Cell Carcinoma. World journal of surgery,41(3):771-779 2017(Mar.) Author:Ohtaki Y, Shimizu K, Aokage K, Nakao M, Yoshida J, Kamiyoshihara M, Sugano M, Takahashi Y, Nakazawa S, Nagashima T, Obayashi K, Hishida T, Tsuboi M, Mori S, Mun M, Okumura S, Igai H, Matsutani N, Mogi A, Kuwano H
Evaluation of gefitinib efficacy according to body mass index, body surface area, and body weight in patients with EGFR-mutated advanced non-small cell lung cancer. Cancer chemotherapy and pharmacology,79(3):497-505 2017(Mar.) Author:Imai H, Kuwako T, Kaira K, Masuda T, Miura Y, Seki K, Sakurai R, Utsugi M, Shimizu K, Sunaga N, Tomizawa Y, Ishihara S, Ishizuka T, Mogi A, Hisada T, Minato K, Takise A, Saito R, Yamada M
Highly sensitive detection of a HER2 12-base pair duplicated insertion mutation in lung cancer using the Eprobe-PCR method. PloS one,12(2):e0171225 2017(Feb.) Author:Takase Y, Usui K, Shimizu K, Kimura Y, Ichihara T, Ohkawa T, Atsumi J, Enokida Y, Nakazawa S, Obayashi K, Ohtaki Y, Nagashima T, Mitani Y, Takeyoshi I
Association between GWAS-identified lung adenocarcinoma susceptibility loci and EGFR mutations in never-smoking Asian women, and comparison with findings from Western populations. Human molecular genetics,26(2):454-465 2017(Jan.) Author:Seow WJ, Matsuo K, Hsiung CA, et al.
The efficacy of thoracoscopic fissureless lobectomy in patients with dense fissures. Journal of thoracic disease,8(12):3691-3696 2016(Dec.) Author:Igai H, Kamiyoshihara M, Yoshikawa R, Osawa F, Kawatani N, Ibe T, Shimizu K
Prognostic significance of b2-adrenergic receptor expression in non-small cell lung cancer. American journal of translational research,8(11):5059-5070 2016(Nov.) Author:Yazawa T, Kaira K, Shimizu K, Shimizu A, Mori K, Nagashima T, Ohtaki Y, Oyama T, Mogi A, Kuwano H
Elemental and immunohistochemical analysis of the lungs and hilar lymph node in a patient with asbestos exposure, a pilot study. Environmental health and preventive medicine,21(6):492-500 2016(Nov.) Author:Koga Y, Satoh T, Kaira K, Koka M, Hisada T, Hirato J, Altan B, Yatomi M, Ono A, Kamide Y, Shimizu Y, Aoki-Saito H, Tsurumaki H, Shimizu K, Mogi A, Ishizuka T, Yamada M, Dobashi K
Risk factors associated with recurrence of surgically resected node-positive non-small cell lung cancer. Surg Today.,46(10):1196-1208 2016(Oct.) Author:Ohtaki Y, Shimizu K, Kaira K, Nagashima T, Obayashi K, Nakazawa S, Kakegawa S, Igai H, Kamiyoshihara M, Nishiyama M, Takeyoshi I.
Analysis of the variation pattern in right upper pulmonary veins and establishment of simplified vein models for anatomical segmentectomy. General thoracic and cardiovascular surgery,64(10):604-611 2016(Oct.) Author:Shimizu K, Nagashima T, Ohtaki Y, Obayashi K, Nakazawa S, Kamiyoshihara M, Igai H, Takeyoshi I, Mogi A, Kuwano H
Neither the maximum tumor size nor solid component size is prognostic in part-solid lung cancer: to be ground-glass opacity or not to be, is that really the question? Journal of thoracic disease,8(9):2334-2336 2016(Sep.) Author:Shimizu K, Ohtaki Y, Nakazawa S, Mogi A, Kuwano H
A convenient method for identifying a small pulmonary nodule using a dyed swab and geometric mapping. Journal of thoracic disease,8(9):2556-2561 2016(Sep.) Author:Kamiyoshihara M, Ibe T, Kawatani N, Ohsawa F, Yoshikawa R, Shimizu K
Quality of life after video-assisted surgery for lung cancer. The Lancet. Oncology,17(8):e318 2016(Aug.) Author:Nakazawa S, Shimizu K, Nagashima T, Mogi A, Kuwano H
Prognostic potential of the MDM2 309T＞G polymorphism in stage I lung adenocarcinoma. Cancer medicine,5(8):1791-1801 2016(Aug.) Author:Enokida Y, Shimizu K, Atsumi J, Kakegawa S, Takase Y, Kaira K, Yashima H, Araki T, Nakazawa S, Ohtaki Y, Nagashima T, Alexander L, Usui K, Ishikawa T, Hayashizaki Y, Takeyoshi I
Association of variations in HLA class II and other loci with susceptibility to EGFR-mutated lung adenocarcinoma. Nature communications,7:12451 2016(Aug.) Author:Shiraishi K, Okada Y, Takahashi A, Kamatani Y, Momozawa Y, Ashikawa K, Kunitoh H, Matsumoto S, Takano A, Shimizu K, Goto A, Tsuta K, Watanabe S, Ohe Y, Watanabe Y, Goto Y, Nokihara H, Furuta K, Yoshida A, Goto K, Hishida T, Tsuboi M, Tsuchihara K, Miyagi Y, Nakayama H, Yokose T, Tanaka K, Nagashima T, Ohtaki Y, Maeda D, Imai K, Minamiya Y, Sakamoto H, Saito A, Shimada Y, Sunami K, Saito M, Inazawa J, Nakamura Y, Yoshida T, Yokota J, Matsuda F, Matsuo K, Daigo Y, Kubo M, Kohno T
Surgical treatment for elderly patients with secondary spontaneous pneumothorax. General thoracic and cardiovascular surgery,64(5):267-272 2016(May) Author:Igai H, Kamiyoshihara M, Ibe T, Kawatani N, Shimizu K
Prognostic significance of β2-adrenergic receptor expression in malignant melanoma. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine,37(5):5971-5978 2016(May) Author:Shimizu A, Kaira K, Mori K, Kato M, Shimizu K, Yasuda M, Takahashi A, Oyama T, Asao T, Ishikawa O
Impact of the Bim Deletion Polymorphism on Survival Among Patients With Completely Resected Non-Small-Cell Lung Carcinoma. Journal of global oncology,2(1):15-25 2016(Feb.) Author:Atsumi J, Shimizu K, Ohtaki Y, Kaira K, Kakegawa S, Nagashima T, Enokida Y, Nakazawa S, Obayashi K, Takase Y, Kawashima O, Kamiyoshihara M, Sugano M, Ibe T, Igai H, Takeyoshi I
Prognostic significance of aromatase and estrogen receptor beta expression in EGFR wild-type lung adenocarcinoma. American journal of translational research,8(1):81-97 2016(Jan.) Author:Tanaka K, Shimizu K, Kakegawa S, Ohtaki Y, Nagashima T, Kaira K, Horiguchi J, Oyama T, Takeyoshi I
A case report: right upper lobectomy with middle lobe preservation after right lower lobectomy. Surgical case reports,1(1):19 2015(Dec.) Author:Igai H, Kamiyoshihara M, Kawatani N, Ibe T, Shimizu K
First-line gefitinib treatment in elderly patients (aged ≥75 years) with non-small cell lung cancer harboring EGFR mutations. Cancer chemotherapy and pharmacology,76(4):761-769 2015(Oct.) Author:Kuwako T, Imai H, Masuda T, Miura Y, Seki K, Yoshino R, Kaira K, Utsugi M, Shimizu K, Sunaga N, Tomizawa Y, Ishihara S, Ishizuka T, Mogi A, Hisada T, Minato K, Takise A, Saito R, Yamada M
Eprobe-mediated screening system for somatic mutations in the KRAS locus. Oncol Rep.,33(6):2719-2727 2015(Jun.) Author:Atsumi J, Hanami T, Enokida Y, Ogawa H, Delobel D, Mitani Y, Kimura Y, Soma T, Tagami M, Takase Y, Ichihara T, Takeyoshi I, Usui K, Hayashizaki Y, Shimizu K.
Clinical significance of coexpression of L-type amino acid transporter 1 (LAT1) and ASC amino acid transporter 2 (ASCT2) in lung adenocarcinoma. Am J Transl Res.,7(6):1126-1139 2015(Jun.) Author:Yazawa T, Shimizu K, Kaira K, Nagashima T, Ohtaki Y, Atsumi J, Obayashi K, Nagamori S, Kanai Y, Oyama T, Takeyoshi I.
An analysis of variations in the bronchovascular pattern of the right upper lobe using three-dimensional CT angiography and bronchography. General thoracic and cardiovascular surgery,63(6):354-360 2015(Jun.) Author:Nagashima T, Shimizu K, Ohtaki Y, Obayashi K, Kakegawa S, Nakazawa S, Kamiyoshihara M, Igai H, Takeyoshi I.
A 3.5-cm Single-Incision VATS Anatomical Segmentectomy for Lung Cancer. Ann Thorac Cardiovasc Surg.,21(2):178-182 2015(Apr.) Author:Kamiyoshihara M, Igai H, Ibe T, Kawatani N, Shimizu K, Takeyoshi I.
Clinicopathological significance of ASC amino acid transporter-2 expression in pancreatic ductal carcinoma. Histopathology.,66(2):234-243 2015(Jan.) Author:Kaira K, Sunose Y, Arakawa K, Sunaga N, Shimizu K, Tominaga H, Oriuchi N, Nagamori S, Kanai Y, Oyama T, Takeyoshi I.
Relationship between CD147 and expression of amino acid transporters (LAT1 and ASCT2) in patients with pancreatic cancer. Am J Transl Res.,7(2):356-363 2015 Author:Kaira K, Arakawa K, Shimizu K, Oriuchi N, Nagamori S, Kanai Y, Oyama T, Takeyoshi I.
Efficacy of platinum combination chemotherapy after first-line gefitinib treatment in non-small cell lung cancer patients harboring sensitive EGFR mutations. ,17(9):702-709 2015 Author:Masuda T, Imai H, Kuwako T, Miura Y, Yoshino R, Kaira K, Shimizu K, Sunaga N, Tomizawa Y, Ishihara S, Mogi A, Hisada T, Minato K, Takise A, Saito R, Yamada M
[Revelation of the assistance for thoracic surgeons by nurse practitioner in Takasaki General Medical Center]. Nihon Geka Gakkai zasshi,115(6):352-356 2014(Nov.) Author:Sugano M, Shimizu K, Murata M, Atsumi J, Ogawa T, Takeyoshi I
Anatomical thoracoscopic segmentectomy for lung cancer. Gen Thorac Cardiovasc Surg.,62(10):586-593 2014(Oct.) Author:Ohtaki Y, Shimizu K.
[Initial report of uniportal video-assisted thoracoscopic lobectomy in Japan]. Kyobu geka. The Japanese journal of thoracic surgery,67(7):540-543 2014(Jul.) Author:Kamiyoshihara M, Igai H, Ibe T, Kawatani N, Shimizu K, Takeyoshi I
Sternal intraosseous schwannoma mimicking breast cancer metastasis. J Cardiothorac Surg.,9:116 2014(Jun.) Author:Igai H, Kamiyoshihara M, Kawatani N, Ibe T, Shimizu K.
Clinicopathological and prognostic significance of interleukin-8 expression and its relationship to KRAS mutation in lung adenocarcinoma. Br J Cancer,110(8):2047-2053 2014(Apr.) Author:Sunaga N, Kaira K, Tomizawa Y, Shimizu K, Imai H, Takahashi G, Kakegawa S, Ohtaki Y, Nagashima T, Kasahara N, Kawashima O, Hisada T, Saito R, Yamada M.
ASC amino-acid transporter 2 (ASCT2) as a novel prognostic marker in non-small cell lung cancer. Br J Cancer,110(8):2030-2039 2014(Apr.) Author:Shimizu K, Kaira K, Tomizawa Y, Sunaga N, Kawashima O, Oriuchi N, Tominaga H, Nagamori S, Kanai Y, Yamada M, Oyama T, Takeyoshi I
[Current surgical treatment of primary chest wall tumor]. Kyobu geka. The Japanese journal of thoracic surgery,67(1):9-14 2014(Jan.) Author:Kawashima O, Kakegawa S, Nagashima T, Ibe T, Nakano T, Shimizu K
Thoracoscopic caudal left lower lobectomy in a patient with fused fissure. Asian J Endosc Surg.,7(4):342-344 2014 Author:Igai H, Kamiyoshihara M, Kawatani N, Ibe T, Shimizu K.
Single-nucleotide polymorphism (c.309T>G) in the MDM2 gene and lung cancer risk. Biomed Rep.,2(5):719-724 2014 Author:Enokida Y, Shimizu K, Kakegawa S, Atsumi J, Takase Y, Miyamae Y, Nagashima T, Ohtaki Y, Kaira K, Sunaga N, Yanagitani N, Yoshino R, Tsunekawa K, Igai H, Kamiyoshihara M, Usui K, Lezhava A, Tomizawa Y, Ishikawa T, Murakami M, Hayashizaki Y, Takeyoshi I.
Single-incision thoracoscopic surgery for spontaneous pneumothorax using multi-degrees of freedom forceps. Ann Thorac Cardiovasc Surg.,20(6):974-979 2014 Author:Igai H, Kamiyoshihara M, Ibe T, Kawatani N, Shimizu K.
Profuse mediastinal hemorrhage due to mediastinitis after a sternal infection. Ann Thorac Cardiovasc Surg.,20:629-631 2014 Author:Kamiyoshihara M, Ibe T, Igai H, Kawatani N, Hayashi H, Shimizu K, Takeyoshi I.
Postrecurrence survival of surgically resected pulmonary adenocarcinoma patients according to EGFR and KRAS mutation status. Molecular and Clinical Oncology,2(2):187-196 2014 Author:Ohtaki Y, Shimizu K, Kakegawa S, Nagashima T,Nakano T, Atsumi J, Enokida Y, Igai H, Ibe T, Sugano M, kamiyoshihara M, Kawashima O, kaira K, Sunaga N, Takeyoshi I.
Novel repair of a defect in the cervical trachea with a thymus pedicle flap. J Thorac Cardiovasc Surg.,147(7):1988-1990 2014 Author:Shimizu K, Nagashima T, Ohtaki Y, Takeyoshi I
Lung metastasectomy for postoperative colorectal cancer in patients with a history of hepatic metastasis. Gen Thorac Cardiovasc Surg.,62(5):314-320 2014 Author:Kamiyoshihara M, Igai H, Kawatani N, Ibe T, Tomizawa N, Obayashi K, Shimizu K, Takeyoshi I.
Assessment of DDR2, BRAF, EGFR and KRAS mutations as therapeutic targets in non-adenocarcinoma lung cancer patients. Mol Clin Oncol.,2(5):714-718 2014 Author:Yashima H, Shimizu K, Araki T, Aomori T, Ohtaki Y, Nagashima T, Enokida Y, Atsumi J, Nakamura T, Takeyoshi I, Yamamoto K.
A resectable pancreatic metastasis from pulmonary adenocarcinoma. Ann Thorac Cardiovasc Surg.,20(3):243-245 2014 Author:Igai H, Kamiyoshihara M, Nagashima T, Ohtaki Y, Shimizu K.
Clinical significance of L-type amino acid transporter 1 expression as a prognostic marker and potential of new targeting therapy in biliary tract cancer. BMC Cancer.,13:482-494 2013(Oct.) Author:Kaira K, Sunose Y, Ohshima Y, Ishioka NS, Arakawa K, Ogawa T, Sunaga N, Shimizu K, Tominaga H, Oriuchi N, Itoh H, Nagamori S, Kanai Y, Yamaguchi A, Segawa A, Ide M, Mori M, Oyama T, Takeyoshi I&0d0a;
Oncogenic KRAS-induced epiregulin overexpression contributes to aggressive phenotype and is a promising therapeutic target in non-small-cell lung cancer. Oncogene.,32(34):4034-4042 2013(Aug.) Author:Sunaga N, Kaira K, Imai H, Shimizu K, Nakano T, Shames DS, Girard L, Soh J, Sato M, Iwasaki Y, Ishizuka T, Gazdar AF, Minna JD, Mori M.
Feasibility trial for adjuvant chemotherapy with docetaxel plus cisplatin followed by single agent long-term administration of S-1 chemotherapy in patients with completely resected non-small cell lung cancer: Thoracic Oncology Research Group Study 0809. Br J Cancer.,109(3):545-551 2013(Aug.) Author:Niho S, Ikeda N, Michimae H, Suzuki K, Sakai H, Kaburagi T, Minato K, Kato T, Okamoto H, Seto T, Hosomi Y, Shimizu K, Oshita F, Kunitoh H, Tsuboi M, Takeuchi M, Watanabe K.
Pulmonary sequestration combined with an aberrant right subclavian artery. Ann Thorac Surg.,96(2):704 2013(Aug.) Author:Kamiyoshihara M, Igai H, Ibe T, Kawatani N, Shimizu K.
Right superior mediastinal lymph node dissection in thoracoscopic surgery using a bipolar sealing device. Innovations (Phila).,8(4):258-263 2013(Jul.) Author:Kamiyoshihara M, Igai H, Ibe T, Kawatani N, Ohtaki Y, Shimizu K, Takeyoshi I.
A peculiar squamous dysplastic lesion presenting as a ground-glass opacity: a case report. Eur Respir J.,41(5):1228-1230 2013(May) Author:Atsumi J, Shimizu K, Nakano T, Kakegawa S, Sano T, Katano M, Hiroshima K, Takeyoshi I.
Pulmonary lobar root clamping and stapling technique: return of the "en masse lobectomy". Gen Thorac Cardiovasc Surg.,61(5):280-291 2013(May) Author:Kamiyoshihara M, Igai H, Ibe T, Ohtaki Y, Atsumi J, Nakazawa S, Tanaka K, Obayashi K, Shimizu K, Takeyoshi I.
Rapid detection of SNP (c.309T>G) in the MDM2 gene by the Duplex SmartAmp method. PLOS ONE,8(4):e60151 2013(Apr.) Author:Enokida Y, Shimizu K, Atsumi J, Lezhava A, Tanaka Y, Kimura Y, Soma T, Hanami T, Kawai Y, Usui K, Okano Y, Kakegawa S, Ogawa H, Miyamae Y, Miyagi Y, Nakayama H, Ishikawa T, Hayashizaki Y, Takeyoshi I
[Lung metastasectomy for postoperative colorectal cancer in patients with a history of hepatic metastasis]. Kyobu geka. The Japanese journal of thoracic surgery,66(4):291-297 2013(Apr.) Author:Kamiyoshihara M, Igai H, Ibe T, Kawatani N, Ando T, Tomizawa N, Ohtaki Y, Atsumi J, Nakazawa S, Obayashi K, Shimizu K, Takeyoshi I
Posterior mediastinal malignant lymphoma mimicking a neurogenic tumor. Ann Thorac Surg.,95(2):e49 2013(Feb.) Author:Ohtaki Y, Shimizu K, Nagashima T, Nakano T, Takeyoshi I
Usefulness of three-dimensional computed tomographic angiography with bronchography for the planning of minimally invasive video-assisted thoracic surgery for intralobar pulmonary sequestration. European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery,43(1):199 2013(Jan.) Author:Nakano T, Shimizu K, Nakano S, Takeyoshi I
A new application of a wound retractor for chest wall surgery. Gen Thorac Cardiovasc Surg,61(1):53-54 2013(Jan.) Author:Igai H, Kamiyoshihara M, Nagashima T, Ohtaki Y, Shimizu K
Anatomical segmentectomy for pneumothorax associated with congenital bronchial atresia. European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery,43(1):198 2013(Jan.) Author:Igai H, Kamiyoshihara M, Nagashima T, Shimizu K
Diagnosis and surgical resection of solitary pulmonary nodules in patients with breast cancer. Mol Clin Oncol,1(1):117-123 2013(Jan.) Author:Tanaka K, Shimizu K, Ohtaki Y, Nakano T, Kamiyoshihara M, Kaira K, Rokutanda N, Horiguchi J, Oyama T, Takeyoshi I.
Roentgenological occult large-cell neuroendocrine carcinoma: Report of a long-term survivor. Respiratory medicine case reports,8(1):14-17 2013 Author:Kamiyoshihara M, Ibe T, Igai H, Kawatani N, Takise A, Itoh H, Shimizu K
Pericardium reconstruction with the starfish heart positioner after extended thymectomy with combined left side pericardium resection. The Annals of thoracic surgery ,94(6):2136-2138 2012(Dec.) Author:Shimizu K,Nakano T,Kakegawa S,Ohtaki Y,Nagashima T,Kamiyoshihara M,Atsumi J,Takeyoshi I
Establishment of a human lung cancer cell line with high metastatic potential to multiple organs: gene expression associated with metastatic potential in human lung cancer. Oncology reports,28(5):1727-1735 2012(Nov.) Author:Nakano T, Shimizu K, Kawashima O, Kamiyoshihara M, Kakegawa S, Sugano M, Ibe T, Nagashima T, Kaira K, Sunaga N, Ohtaki Y, Atsumi J, Takeyoshi I
An immunoglobulin G4-related disease mimicking postoperative lung cancer recurrence. Mod Rheumatol ,22(5):787-790 2012(Sep.) Author:Nakazawa S, Shimizu K, Nakano T, Kakegawa S, Atsumi J, Kamiyoshihara M, Hirato J, Takeyoshi I
A case of primary angiosarcoma of the lung presenting as a hemorrhagic bronchial tumor. Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia,18(4):347-351 2012(Aug.) Author:Kakegawa S, Kawashima O, Ibe T, Ujita M, Iwashina M, Nakano T, Shimizu K
Effect of landiolol hydrochloride, an ultra-short-acting beta 1-selective blocker, on supraventricular tachycardia, atrial fibrillation and flutter after pulmonary resection. J Clin Pharm Ther ,37(4):431-435 2012(Aug.) Author:Nakano T, Shimizu K, Kawashima O, Kamiyoshihara M, Nagashima T, Ibe T, Takeyoshi I
Prognostic significance of L-type amino-acid transporter 1 expression in surgically resected pancreatic cancer. Br J Cancer ,107(4):632-638 2012(Aug.) Author:Kaira K, Sunose Y, Arakawa K, Ogawa T, Sunaga N, Shimizu K, Tominaga H, Oriuchi N, Itoh H, Nagamori S, Kanai Y, Segawa A, Furuya M, Mori M, Oyama T, Takeyoshi I
Segmentectomy guided by three-dimensional computed tomography angiography and bronchography. Interact Cardiovasc Thorac Surg.,15(2):194-196 2012(Aug.) Author:Shimizu K, Nakano T, Kamiyoshihara M, Takeyoshi I
A useful technique for specimen extraction from the thorax: the vacuum-packing method. European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery ,41(5):1126-1128 2012(May) Author:Kamiyoshihara M, Igai H, Nagashima T, Shimizu K
Oncogenic KRAS-induced interleukin-8 overexpression promotes cell growth and migration and contributes to aggressive phenotypes of non-small cell lung cancer. International journal of cancer,130(8):1733-1744 2012(Apr.) Author:Sunaga N, Imai H, Shimizu K, Shames DS, Kakegawa S, Girard L, Sato M, Kaira K, Ishizuka T, Gazdar AF, Minna JD, Mori M
Rationale of Miyamoto's technique for reconstruction of tracheal carina. General thoracic and cardiovascular surgery,60(2):71-72 2012(Feb.) Author:Shimizu K
Review of the treatment of non-small cell lung cancer with gefitinib. Clin Med Insights Oncol.,6:407-421 2012 Author:Araki T, Yashima H, Shimizu K, Aomori T, Hashita T, Kaira K, Nakamura T, Yamamoto K.
Unanticipated troubles in video-assisted thoracic surgery: a proposal for the classification of troubleshooting. Asian J Endosc Surg.,5(2):69-77 2012 Author:Kamiyoshihara M, Nagashima T, Igai H, Ohtaki Y, Atsumi J, Shimizu K, Takeyoshi I.
Correlation between computed tomography findings and epidermal growth factor receptor and Kras gene mutations in patients with pulmonary adenocarcinoma. Oncol Rep.,26(5):1205-1211 2011(Nov.) Author:Sugano M, Shimizu K, Nakano T, Kakegawa S, Miyamae Y, Kaira K, Araki T, Kamiyoshihara M, Kawashima O, Takeyoshi I
Clinical screening assay for EGFR exon 19 mutations using PNA-clamp smart amplification process version 2 in lung adenocarcinoma. Oncol Rep.,26(5):1213-1219 2011(Nov.) Author:Takuya Araki, Kimihiro Shimizu, Tomonori Nakamura, Masaru Baba, Yuki Kawai, Katsunori Nakamura, Yasumasa Mitani, Kyoko Obayashi, Tohru Aomori, Yukiyoshi Fujita, Yohei Miyamae, Seiichi Kakegawa, Kyoichi Kaira, Alexander Lezhava, Yoshihide Hayashizaki, Izumi Takeyoshi, Koujirou Yamamoto
Clinicopathological Features of Lung Adenocarcinoma with KRAS Mutations. Cancer,117(18):4257-4266 2011(Sep.) Author:Kakegawa S, Shimizu K, Sugano M, Miyamae Y, Kaira K, Araki T, Nakano T, Kamiyoshihara M, Kawashima O, Takeyoshi I
Pulmonary large cell carcinoma mimicking an infected thoracoabdominal aortic aneurysm. Journal of Thoracic Oncology,6(7):1293-1294 2011(Jul.) Author:Nakano T, Shimizu K, Takahashi T, Mohara J, Koike N, Kawashima O, Kamiyoshihara M, Sugano M, Ibe T, Kakegawa S, Nagashima T, Atsumi J, Takeyoshi I.
Video-assisted thoracic lobectomy with bronchoplasty for lung cancer, with special reference to methodology. Interact Cardiovasc Thorac Surg.,12(4):534-538 2011(Apr.) Author:Kamiyoshihara M, Nagashima T, Igai H, Atsumi J, Ibe T, Kakegawa S, Shimizu K.
Significance of epidermal growth factor receptor gene mutations in squamous cell lung carcinoma. Oncol Rep.,25(4):921-928 2011(Apr.) Author:Miyamae Y, Shimizu K, Hirato J, Araki T, Tanaka K, Ogawa H, Kakegawa S, Sugano M, Nakano T, Mitani Y, Kaira K, Takeyoshi I
The role of [¹⁸F] fluorodeoxyglucose positron emission tomography in thymic epithelial tumors. Cancer Imaging.,11(1):195-201 2011(Jan.) Author:Kaira K, Sunaga N, Ishizuka T, Shimizu K, Yamamoto N.
Cystoperitoneal shunt for a giant intrathoracic meningocele under local anesthesia. Ann Thorac Surg.,91(1):317-319 2011(Jan.) Author:Tanaka K, Shimizu K, Kakegawa S, Oshima K, Takeyoshi I
A simple, new technique for identifying the cut line in the bronchus in bronchoplasty using a butterfly needle. Eur J Cardiothorac Surg.,39(1):132-133 2011(Jan.) Author:Kamiyoshihara M, Nagashima T, Ibe T, Shimizu K.
A systemic review of PET and biology in lung cancer. Am J Transl Res.,3(4):383-391 2011 Author:Kaira K, Oriuchi N, Sunaga N, Ishizuka T, Shimizu K, Yamamoto N.
Inhibition of L-type amino acid transporter 1 has antitumor activity in non-small cell lung cancer. ,30(12):4819-4828 2010(Dec.) Author:Imai H, Kaira K, Oriuchi N, Shimizu K, Tominaga H, Yanagitani N, Sunaga N, Ishizuka T, Nagamori S, Promchan K, Nakajima T, Yamamoto N, Mori M, Kanai Y.
Wedge tracheobronchoplasty technique for primary pulmonary carcinoma of the right upper bronchus. Clinical lung cancer,11(6):426-428 2010(Nov.) Author:Kamiyoshihara M, Nagashima T, Takise A, Shimizu K
Comparison of L-type amino acid transporter 1 expression and L-[3-18F]-α-methyl tyrosine uptake in outcome of non-small cell lung cancer. Nucl Med Biol. ,37(8):911-916 2010(Nov.) Author:Kaira K, Oriuchi N, Shimizu K, Imai H, Tominaga H, Yanagitani N, Sunaga N, Hisada T, Ishizuka T, Kanai Y, Oyama T, Mori M, Endo K.
Serial chest films are needed after a diagnosis of pneumopericardium because of risk of cardiac herniation. Ann Thorac Surg.,90(5):1705-1707 2010(Nov.) Author:Kamiyoshihara M, Nagashima T, Baba S, Shimizu K, Takeyoshi I.
Is epidural analgesia necessary after video-assisted thoracoscopic lobectomy? Asian Cardiovasc Thorac Ann.,18(5):464-468 2010(Oct.) Author:Kamiyoshihara M, Nagashima T, Ibe T, Atsumi J, Shimizu K, Takeyoshi I.
Prognostic significance of L-type amino acid transporter 1 (LAT1) and 4F2 heavy chain (CD98) expression in surgically resectable stage III non-small cell lung cancer. Exp Ther Med.,1(5):799-808 2010(Sep.) Author:Kaira K, Oriuchi N, Imai H, Shimizu K, Yanagitani N, Sunaga N, Hisada T, Kawashima O, Kamide Y, Ishizuka T, Kanai Y, Nakajima T, Mori M.
High-grade neuroendocrine carcinoma of the lung shows increased thymidylate synthase expression compared to other histotypes. J Surg Oncol.,102(1):11-17 2010(Jul.) Author:Ibe T, Shimizu K, Nakano T, Kakegawa S, Kamiyoshihara M, Nakajima T, Kaira K, Takeyoshi I.
A phase II study of amrubicin, a synthetic 9-aminoanthracycline, in patients with previously treated lung cancer.&0d0a;&0d0a;&0d0a;&0d0a;&0d0a; Lung Cancer. ,69(1):99-104 2010(Jul.) Author:Kaira K, Sunaga N, Tomizawa Y, Yanagitani N, Shimizu K, Imai H, Utsugi M, Iwasaki Y, Iijima H, Tsurumaki H, Yoshii A, Fueki N, Hisada T, Ishizuka T, Saito R, Mori M.
Phase 2 study of S-1 plus carboplatin in patients with advanced non-small cell lung cancer.&0d0a;&0d0a;&0d0a;&0d0a; Lung Cancer. ,68(2):253-257 2010(May) Author:Kaira K, Sunaga N, Yanagitani N, Imai H, Utsugi M, Iwasaki Y, Shimizu K, Iijima H, Tsurumaki H, Tomizawa Y, Hisada T, Ishizuka T, Saito R, Mori M.&0d0a;
Decreased interstitial FOXP3(+) lymphocytes in usual interstitial pneumonia with discrepancy of CXCL12/CXCR4 axis. Int J Immunopathol Pharmacol.,23(2):449-461 2010(Apr.) Author:Shimizu Y, Dobashi K, Endou K, Ono A, Yanagitani N, Utsugi M, Sano T, Ishizuka T, Shimizu K, Tanaka S, Mori M.
Mutation detection of epidermal growth factor receptor and KRAS genes using the smart amplification process version 2 from formalin-fixed, paraffin-embedded lung cancer tissue. J Mol Diagn.,12(2):257-264 2010(Mar.) Author:Miyamae Y, Shimizu K, Mitani Y, Araki T, Kawai Y, Baba M, Kakegawa S, Sugano M, Kaira K, Lezhava A, Hayashizaki Y, Yamamoto K, Takeyoshi I.&0d0a;
Primary thymic mucosa-associated lymphoid tissue lymphoma: diagnostic tips. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer,5(1):117-121 2010(Jan.) Author:Shimizu K, Yoshida J, Kakegawa S, Astumi J, Kaira K, Oshima K, Miyanaga T, Kamiyoshihara M, Nagai K, Takeyoshi I
【遺伝子診断の現場利用】 肺がん診療におけるポイントオブケア遺伝子診断 EGFR・KRAS遺伝子変異診断の臨床応用と今後の展望 Medical Bio,7(1):28-35 2010(Jan.) Author:清水 公裕
Analysis on the co-localization of asbestos bodies and Fas or CD163 expression in asbestos lung tissue by in-air micro-pixe. Int J Immunopathol Pharmacol.,23(1):1-11 2010(Jan.) Author:Matsuzaki S, Shimizu Y, Dobashi K, Nagamine T, Satoh T, Ohkubo T, Yokoyama A, Ishii Y, Kamiya T, Arakawa K, Makino S, Utsugi M, Ishizuka T, Tanaka S, Shimizu K, Mori M.
Usefulness of peptide nucleic acid (PNA)-clamp smart amplification process version 2 (SmartAmp2) for clinical diagnosis of KRAS codon 12 mutations in lung adenocarcinoma: comparison of PNA-clamp SmartAmp2 and PCR-related methods. J Mol Diagn.,12(1):118-124 2010(Jan.) Author:Araki T, Shimizu K, Nakamura K, Nakamura T, Mitani Y, Obayashi K, Fujita Y, Kakegawa S, Miyamae Y, Kaira K, Ishidao T, Lezhava A, Hayashizaki Y, Takeyoshi I, Yamamoto K.
Clinicopathological and therapeutic significance of CXCL12 expression in lung cancer. Int J Immunopathol Pharmacol,23(1):153-164 2010(Jan.) Author:Imai H, Sunaga N, Shimizu Y, Kakegawa S, Shimizu K, Sano T, Ishizuka T, Oyama T, Saito R, Minna JD, Mori M.
CD98 expression is associated with poor prognosis in resected non-small-cell lung cancer with lymph node metastases.&0d0a;&0d0a;&0d0a;&0d0a; Ann Surg Oncol. ,16(12):3473-3481 2009(Dec.) Author:Kaira K, Oriuchi N, Imai H, Shimizu K, Yanagitani N, Sunaga N, Hisada T, Kawashima O, Kamide Y, Ishizuka T, Kanai Y, Nakajima T, Mori M.
18F-FMT Uptake Seen Within Primary Cancer on PET Helps Predict Outcome of Non-Small Cell Lung Cancer. J Nucl Med,50(11):1770-1776 2009(Nov.) Author:Kaira K, Oriuchi N, Shimizu K, Tominaga H, Yanagitani N, Sunaga N, Ishizuka T, Kanai Y, Mori M, Endo K.
Prognostic significance of L-type amino acid transporter 1 (LAT1) and 4F2 heavy chain (CD98) expression in stage I pulmonary adenocarcinoma. Lung Cancer. ,66(1):120-126 2009(Oct.) Author:Kaira K, Oriuchi N, Imai H, Shimizu K, Yanagitani N, Sunaga N, Hisada T, Ishizuka T, Kanai Y, Nakajima T, Mori M.
Phase I study of oral S-1 plus Cisplatin with concurrent radiotherapy for locally advanced non-small-cell lung cancer.&0d0a; Int J Radiat Oncol Biol Phys.,75(1):109-14 2009(Sep.) Author:Kaira K, Sunaga N, Yanagitani N, Kawata T, Utsugi M, Shimizu K, Ebara T, Kawamura H, Nonaka T, Ishikawa H, Sakurai H, Suga T, Hara K, Hisada T, Ishizuka T, Nakano T, Mori M.
L-type amino acid transporter 1 (LAT1) is frequently expressed in thymic carcinomas but is absent in thymomas.&0d0a;&0d0a;&0d0a;&0d0a; J Surg Oncol. ,99(7):433-438 2009(Jun.) Author:Kaira K, Oriuchi N, Imai H, Shimizu K, Yanagitani N, Sunaga N, Hisada T, Ishizuka T, Kanai Y, Endou H, Nakajima T, Mori M.
Correlation of angiogenesis with 18F-FMT and 18F-FDG uptake in non-small cell lung cancer.&0d0a;&0d0a;&0d0a;&0d0a; Cancer Sci. ,100(4):753-758 2009(Apr.) Author:Kaira K, Oriuchi N, Shimizu K, Ishikita T, Higuchi T, Imai H, Yanagitani N, Sunaga N, Hisada T, Ishizuka T, Kanai Y, Endou H, Nakajima T, Endo K, Mori M.
CXCR4+FOXP3+CD25+ lymphocytes accumulate in CXCL12-expressing malignant pleural mesothelioma. Int J Immunopathol Pharmacol.,22(1):43-51 2009(Mar.) Author:Shimizu Y, Dobashi K, Imai H, Sunaga N, Ono A, Sano T, Hikino T, Shimizu K, Tanaka S, Ishizuka T, Utsugi M, Mori M.
Evaluation of thoracic tumors with 18F-FMT and 18F-FDG PET-CT: A clinicopathological study. Int J Cancer,124(4):1152-1160 2009(Mar.) Author:Kaira K, Oriuchi N, Shimizu K, Ishikita T, Higuchi T, Imai H, Yanagitani N, Sunaga N, Hisada T, Ishizuka T, Kanai Y, Endou H, Nakajima T, Endo K, Mori M.
Prognostic significance of L-type amino acid transporter 1 (LAT1) and 4F2 heavy chain (CD98) expression in early stage squamous cell carcinoma of the lung.&0d0a; Cancer Sci. ,100(2):249-254 2009(Feb.) Author:Kaira K, Oriuchi N, Imai H, Shimizu K, Yanagitani N, Sunaga N, Hisada T, Ishizuka T, Kanai Y, Endou H, Nakajima T, Mori M.&0d0a;
l-type amino acid transporter 1 and CD98 expression in primary and metastatic sites of human neoplasms.&0d0a;&0d0a;&0d0a;&0d0a; Cancer Sci. ,99(12):2380-2386 2008(Dec.) Author:Kaira K, Oriuchi N, Imai H, Shimizu K, Yanagitani N, Sunaga N, Hisada T, Tanaka S, Ishizuka T, Kanai Y, Endou H, Nakajima T, Mori M.
Prognostic significance of L-type amino acid transporter 1 expression in resectable stage I-III nonsmall cell lung cancer.&0d0a; Br J Cancer. ,98(4):742-748 2008(Aug.) Author:Kaira K, Oriuchi N, Imai H, Shimizu K, Yanagitani N, Sunaga N, Hisada T, Tanaka S, Ishizuka T, Kanai Y, Endou H, Nakajima T, Mori M.
In-air micro-particle induced X-ray emission analysis of asbestos and metals in lung tissue. International Journal of Immunopathology and Pharmacology,21(3):567-576 2008(Jul.) Author:Shimizu Y, Dobashi K, Kusakbe T, Nagamine T, Oikawa M, Satoh T, Haga J, Ishii Y, Ohkubo T, Kamiya T, Arakawa K, Sano T, Tanaka S, Shimizu K, Matsuzaki S, Utsugi M, Mori M
Phase I trial of oral S-1 plus gemcitabine in elderly patients with nonsmall cell lung cancer.&0d0a; Anticancer Drugs. ,19(3):289-294 2008(Mar.) Author:Kaira K, Sunaga N, Yanagitani N, Aoki H, Kawata T, Utsugi M, Shimizu Y, Shimizu K, Hisada T, Ishizuka T, Mori M.&0d0a;
Expression of L-type amino acid transporter 1 (LAT1) in neuroendocrine tumors of the lung.&0d0a; Pathol Res Pract. ,204(8):553-561 2008 Author:Kaira K, Oriuchi N, Imai H, Shimizu K, Yanagitani N, Sunaga N, Hisada T, Kawashima O, Iijima H, Ishizuka T, Kanai Y, Endou H, Nakajima T, Mori M.
Fluorine-18-alpha-methyltyrosine positron emission tomography for diagnosis and staging of lung cancer: a clinicopathologic study. Clin Cancer Res.,13(21):6369-6378 2007(Nov.) Author:Kaira K, Oriuchi N, Otani Y, Shimizu K, Tanaka S, Imai H, Yanagitani N, Sunaga N, Hisada T, Ishizuka T, Dobashi K, Kanai Y, Endou H, Nakajima T, Endo K, Mori M.
Phase II prospective study of the efficacy of gefitinib for the treatment of stage III/IV non-small cell lung cancer with EGFR mutations, irrespective of previous chemotherapy. Lung Cancer.,56(3):383-389 2007(Jun.) Author:Sunaga N, Tomizawa Y, Yanagitani N, Iijima H, Kaira K, Shimizu K, Tanaka S, Suga T, Hisada T, Ishizuka T, Saito R, Dobashi K, Mori M.
Mediastinal lymph node metastases and visceral pleural invasion in nonsmall cell lung cancer patients. Ann Thorac Surg.,81(5):1947 2006(May) Author:Shimizu K,Yoshida J,Nagai K,Morishita Y
月経随伴性気胸に対し横隔膜部分切除後に横隔膜ヘルニアを生じた1例 The Kitakanto Medical Journal,55(3):269-272 2005(Aug.) Author:懸川 誠一, 上吉原 光宏, 大谷 嘉己, 清水 公裕, 森下 靖雄
Visceral pleural invasion is an invasive and aggressive indicator of non-small cell lung cancer. The Journal of thoracic and cardiovascular surgery,130(1):160-165 2005(Jul.) Author:Shimizu K, Yoshida J, Nagai K, Nishimura M, Ishii G, Morishita Y, Nishiwaki Y
Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) in the thymus: report of four cases. Japanese journal of clinical oncology,35(7):412-416 2005(Jul.) Author:Shimizu K, Ishii G, Nagai K, Yokose T, Ishizawa K, Tamaru J, Yoshida J, Nishimura M, Ochiai A
気管支瘻に対する血管塞栓用コイル留置およびフィブリン糊充填による1治験例 The Kitakanto Medical Journal,55(2):155-159 2005(May) Author:菅野 雅之, 大谷 嘉己, 清水 公裕, 堀口 淳, 森下 靖雄
Successful Treatment of Subarachnoid ？ Pleural FistulaUsing Pericardial Fat Pad and Fibrin Glue after Chest Wall Resection for Lung Cancer. Gen Thorac Cardiovasc Surg.,53(2):93-96 2005 Author:Shimizu K, Otani Y, Ibe T, Kawashima O, Kamiyoshihara M and Morishita Y.
Visceral pleural invasion classification in non-small cell lung cancer: a proposal on the basis of outcome assessment. The Journal of thoracic and cardiovascular surgery,127(6):1574-1578 2004(Jun.) Author:Shimizu K, Yoshida J, Nagai K, Nishimura M, Yokose T, Ishii G, Nishiwaki Y
Pathogenetic and biologic significance of TP14ARF alterations in nonsmall cell lung carcinoma. Cancer Genet Cytogenet.,141(1):5-13 2003(Feb.) Author:Park MJ, Shimizu K, Nakano T, Park YB, Kohno T, Tani M, Yokota J.
Treatment strategy for chylothorax after pulmonary resection and lymph node dissection for lung cancer. J Thorac Cardiovasc Surg.,124(3):499-502 2002(Sep.) Author:Shimizu K, Yoshida J, Nishimura M, Takamochi K, Nakahara R, Nagai K.
Successful management of solitary malar metastasis from lung cancer Lung cancer. Lung Cancer.,36(3):337-339 2002(Jun.) Author:Shimizu K, Nagai K, Yoshida J, Nishimura M, Hayashi R, Yokose T.
Alterations in the INK4a/ARF locus and their effects on the growth of human osteosarcoma cell lines. Cancer Genet Cytogenet.,133(2):105-111 2002(Mar.) Author:Park YB, Park MJ, Kimura K, Shimizu K, Lee SH, Yokota J.
Absence of p51 alteration in human ovarian cancer. Int J Oncol.,18(3):549-552 2001(Mar.) Author:Shinozaki H, Okamoto A, Shimizu K, Saito M, Yokota J, Ochiai K.
Isolation of a novel actin-related gene expressed in low-metastatic PC-14 human lung adenocarcinoma. Biochem Biophys Res Commun.,280(1):61-67 2001 Author:Shindo-Okada N, Shimizu K.
Absence of germline CHK2 mutations in familial gastric cancer. Jpn J Cancer Res.,91(9):875-879 2000(Sep.) Author:Kimura K, Shinmura K, Yoshimura K, Shimizu K, Katai H, Beppu Y, Moriya H, Yokota J.
Molecular cloning of a novel NF2/ERM/4.1 superfamilygene, ehm2, that is expressed in high-metastatic K1735 murine melanoma cells. Genomics.,65(2):113-120 2000(Apr.) Author:Shimizu K, Nagamachi Y, Tani M, Kimura K, Shiroishi T, Wakana S, Yokota J.
Somatic mutations and genetic polymorphisms of the PPP1R3 gene in patients with several types of cancers. Oncogene.,19(6):836-840 2000(Feb.) Author:Takakura S, Kohno T, Shimizu K, Ohwada S, Okamoto A, Yokota J.
Absence of p51 mutation in human hepatocellular carcinoma. Cancer Lett.,148(2):161-164 2000(Feb.) Author:Hamada K, Koyama T, Shimizu K, Ikawa S, Kawate S, Yokota J, Ohwada S, Morishita Y.
Suicidal gene therapy for pleural metastasis of lung cancer by liposome-mediated transfer of herpes simplex virus thymidine kinase gene. Cancer Gene Ther.,6(6):546-553 1999(Nov.) Author:Nagamachi Y, Tani M, Shimizu K, Yoshida T, Yokota J.
The autocrine motility factor receptor gene encodes a novel type of seven transmembrane protein. (jointly authored) FEBS Lett,456:295-300 1999(Aug.) Author:Kimihiro Shimizu, Masachika Tani, WATANABE HIDEOMI, Yasuhiro Nagamachi, Yasufumi Niinaka, Toshihiko Shiroishi, Susumu Ohwada, Avraham Raz, Jun Yokota.
Mutation and expression of the p51 gene in human lung cancer. Neoplasia.,1:71-79 1999 Author:Shimizu K, Tani M, Kawahara C, Kohno T, Ishimoto O, Ikawa S, Yokota J.
Orthotopic growth and metastasis of human non-small cell lung carcinoma cell injected into the pleural cavity of nude mice. Cancer Lett.,127(1-2):203-209 1998(May) Author:Nagamachi Y, Tani M, Shimizu K, Tsuda H, Niitsu Y, Yokota J.
Prognostic potential of MDM2 309T>G polymorphism in stage I lung adenocarcinoma. ASCO 2014 2014
Significance of the estrogen signaling pathway in EGFR wild-type lung adenocarcinoma. ASCO 2014 2014
ASC amino acid transporter 2 (ASCT2) as a novel prognostic marker in non-small cell lung cancer 6th Asian Oncology Summit and 10th Annual Conference of the Organisation &0d0a;for Oncology and Translational Research 2014
左肺下葉sleeve切除のKnack and pitfalls 口径差の調整に気管支縫縮は必要か？ 2013
Total Thoracoscopic Pulmonary Segmentectomy Guided by 3-Dimensional Computed Tomography Angiography and Bronchography 48th Congress of the European Society of the surgical research 2013
Diagnosis and surgical resection of solitary pulmonary nodules in patients with breast cancer 15th world conference of lung cancer 2013
原発性肺癌におけるN2skipリンパ節転移症例の検討 The Japanese Journal of THORACIC AND CARDIOVASCULAR SURGERY 2005(Sep.) Presenter:永島 宗晃, 川島 修, 菅野 雅之, 野内 達人, 清水 公裕, 大谷 嘉己, 森下 靖雄
重症筋無力症を合併した胸腺腫切除例の検討 The Japanese Journal of THORACIC AND CARDIOVASCULAR SURGERY 2005(Sep.) Presenter:伊部 崇史, 大谷 嘉己, 清水 公裕, 中野 哲宏, 森下 靖雄
非小細胞肺がんにおけるEGFR遺伝子変異と臨床病理学的因子の検討 The Japanese Journal of THORACIC AND CARDIOVASCULAR SURGERY 2005(Sep.) Presenter:中野 哲宏, 大谷 嘉己, 清水 公裕, 森下 靖雄
何が肺癌術後患者を苦しめQOLを低下させているのか? 開胸術後症候群postthoracotomy pain syndrome(PTPS)を中心に The Japanese Journal of THORACIC AND CARDIOVASCULAR SURGERY 2004(Sep.) Presenter:清水 公裕, 大谷 嘉己, 伊部 崇史, 森下 靖雄
局所進行肺癌に対する集学的治療の現状と展望 局所進行肺癌に対する集学的治療としての選択的動注化学療法 The Japanese Journal of THORACIC AND CARDIOVASCULAR SURGERY 2003(Oct.) Presenter:清水 公裕, 大谷 嘉己, 川島 修, 菅野 雅之, 伊部 崇史, 懸川 誠一, 森下 靖雄
肺原発多形癌の臨床病理学的検討 The Japanese Journal of THORACIC AND CARDIOVASCULAR SURGERY 2003(Oct.) Presenter:懸川 誠一, 川島 修, 菅野 雅之, 清水 公裕, 大谷 嘉己, 森下 靖雄
急激な経過を示した巨細胞型大細胞癌の1切除例 The Japanese Journal of THORACIC AND CARDIOVASCULAR SURGERY 2001(Mar.) Presenter:清水 公裕, 西村 光世, 吉田 純司, 中原 理恵, 中嶋 隆, 船井 和仁, 永井 完治
放射線・化学療法後の再発に対し,Salvage Surgeryを行った胸部食道癌の1例 The Japanese Journal of THORACIC AND CARDIOVASCULAR SURGERY 2001(Mar.) Presenter:後藤田 直人, 西村 光世, 吉田 純司, 清水 公裕, 中嶋 隆, 船井 和仁, 永井 完治
研究者総覧
